Stephenson reported adjusted FFO of $250 million ($0.80 per share) and FAD of $238 million ($0.76 per share) . He said fourth-quarter FAD increased by one cent compared with the third quarter, driven largely by incremental revenue from the timing and completion of $485 million in new investments during the third and fourth quarters , as well as approximately $1 million of lower net interest expense following debt payoffs. These benefits were partially offset by the impact of $100 million in asset sales and ...

Omega Healthcare Investors (NYSE:OHI) Q4 2025 Earnings call February 05, 2026 10:00 AM ET Company ParticipantsBob Stephenson - CFOJohn Pawlowski - Managing Director, ResidentialMatthew Gourmand - PresidentMegan Krull - Senior Vice President, Data Intelligence and Government RelationsMichele Reber - Head of Investor RelationsNick Joseph - Head of U.S. Real Estate and LodgingTaylor C. Pickett - CEOVikas Gupta - CIOOperatorThank you for standing by. My name is Van, and I will be your conference operator today. ...

Omega Healthcare Investors (NYSE:OHI) Q4 2025 Earnings call February 05, 2026 10:00 AM ET Company ParticipantsBob Stephenson - CFOJohn Kilichowski - Vice President in Equity ResearchJohn Pawlowski - Managing Director, ResidentialJuan Sanabria - Managing Director on Equity ResearchJulian Blouin - Vice President, Real Estate Investment ResearchMatthew Gourmand - PresidentMegan Krull - Senior Vice President, Data Intelligence and Government RelationsMichael Carroll - Managing Director on Equity ResearchMichele ...

Omega Healthcare Investors (NYSE:OHI) Q4 2025 Earnings call February 05, 2026 10:00 AM ET Speaker4Thank you for standing by. My name is Van, and I will be your conference operator today. At this time, I would like to welcome everyone to the Omega Healthcare Investors, Inc. Fourth Quarter Earnings Conference Call. All lines have been placed on mute to prevent any background noise, and after the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this tim ...

分组1 - Omega Healthcare Investors reported quarterly funds from operations (FFO) of $0.8 per share, exceeding the Zacks Consensus Estimate of $0.79 per share, and up from $0.74 per share a year ago, representing an FFO surprise of +1.69% [1] - The company achieved revenues of $319.22 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 0.06%, and an increase from year-ago revenues of $279.32 million [2] - Over the last four quarters, Omega Healthcare Investors has surpassed consensus FFO estimates three times and revenue estimates two times [2] 分组2 - The stock has underperformed the market, losing about 3.2% since the beginning of the year compared to the S&P 500's gain of 1.1% [3] - The current consensus FFO estimate for the coming quarter is $0.80 on revenues of $325.55 million, and for the current fiscal year, it is $3.26 on revenues of $1.33 billion [7] - The Zacks Industry Rank indicates that the REIT and Equity Trust - Other sector is currently in the bottom 28% of over 250 Zacks industries, suggesting potential challenges for stock performance [8]

Financial Performance - Net income for Q4 2025 was $172 million, or $0.55 per diluted share, compared to $116 million, or $0.41 per diluted share for Q4 2024, representing a 48.3% increase in net income year-over-year[4] - Adjusted Funds From Operations (AFFO) for Q4 2025 was $250 million, or $0.80 per diluted share, up from $214 million, or $0.74 per diluted share in Q4 2024, reflecting a 16.8% increase[4] - Funds Available for Distribution (FAD) for Q4 2025 was $238 million, or $0.76 per diluted share, compared to $202 million, or $0.70 per diluted share in Q4 2024, indicating an 17.8% increase[4] - Total revenues for the year ended December 31, 2025, increased to $1,190,099, up 13.2% from $1,051,390 in 2024[47] - Net income for the year ended December 31, 2025, was $609,467, representing a 46% increase from $417,804 in 2024[49] - Nareit Funds From Operations (FFO) for the year ended December 31, 2025, reached $898,907, a 22.5% increase compared to $733,912 in 2024[49] - Adjusted Funds From Operations (AFFO) for the year ended December 31, 2025, totaled $946,155, up 21.6% from $778,137 in 2024[49] Investments and Acquisitions - Total new investments in 2025 amounted to $1.1 billion, including $680 million in real estate acquisitions, $69 million in real estate loans, and $342 million in investments in unconsolidated entities[9] - The company completed $119 million in real estate acquisitions in February 2026, further expanding its portfolio[14] - In January 2026, the company acquired a 9.9% equity interest in the Saber OpCo JV for $93 million, with expected quarterly cash distributions equivalent to an annualized yield of 8%[12] Debt and Financing - The company repaid $1.27 billion of aggregate debt in Q4 2025, contributing to a total of $1.7 billion in debt repayments for the year[4][9] - The company issued 5.5 million Omega OP Units valued at $222 million in Q4 2025 as part of its investment in the Saber PropCo JV[4] - The Company entered into a new $2 billion ATM Program in November 2025, replacing a previous $1.25 billion program[4] - The Company repaid $600 million of 5.25% senior unsecured notes at par value on October 15, 2025[25] - A total of $428.5 million term loan was repaid prior to its scheduled maturity using available cash and proceeds from the 2028 Term Loan[27] - The Company drew the full commitment on its $300 million delayed draw unsecured term loan facility in November 2025[26] Cash and Liquidity - Total cash and cash equivalents were reported at $27.0 million as of December 31, 2025, with $1.8 billion in undrawn capacity under its unsecured revolving credit facility[28] - The Company expects approximately $15 million to $25 million per quarter in asset sales throughout 2026[31] - Cash and cash equivalents significantly decreased to $27,024 as of December 31, 2025, from $518,340 in 2024[45] Shareholder Returns - The company declared a quarterly cash dividend of $0.67 per share, payable on February 17, 2026[29] - The company declared dividends of $0.67 per common share for both the three months and year ended December 31, 2025, consistent with 2024[47] - The company reported a total of 295,539 common shares outstanding as of December 31, 2025, an increase from 279,129 shares in 2024[45] Non-GAAP Measures - Adjusted FFO is calculated as Nareit FFO excluding non-cash stock-based compensation and certain revenue and expense items[53] - FAD is calculated as Adjusted FFO less non-cash expenses, including amortization of deferred financing costs and straight-line rent[53] - The Company believes that Adjusted FFO and FAD provide an enhanced measure of operating performance for its core portfolio as a REIT[53] - Non-GAAP measures like FAD are used for performance-based compensation metrics for officers[54] - The Company excludes depreciation, amortization, and impairments to facilitate comparisons of operating performance between periods[54] - These non-GAAP measures should not be considered substitutes for GAAP measures, including net income[54] - The computation of Adjusted FFO and FAD may not be comparable to similar measures reported by other REITs[53] - The Company believes these measures assist users in analyzing its operating performance[54] - Investors should not rely on non-GAAP measures as indicators of liquidity or cash flow[54] - The Company emphasizes that these measures are not measures of financial performance under GAAP[54]

Company Overview - Omega Healthcare Investors (OHI) currently holds a Momentum Style Score of A, indicating strong potential for momentum investing [3] - The company has a Zacks Rank of 2 (Buy), suggesting it is positioned for outperformance in the market [4] Price Performance - Over the past week, OHI shares increased by 1.02%, while the Zacks REIT and Equity Trust - Other industry rose by 1.9% [6] - In a longer time frame, OHI shares have risen 13.08% over the past quarter and 21.04% over the last year, significantly outperforming the S&P 500, which moved 2.42% and 14.97% respectively [7] Trading Volume - OHI's average 20-day trading volume is 1,386,587 shares, which serves as a bullish indicator when combined with rising stock prices [8] Earnings Outlook - In the past two months, one earnings estimate for OHI has increased, while none have decreased, raising the consensus estimate from $3.08 to $3.09 [10] - For the next fiscal year, one estimate has also moved upwards with no downward revisions noted [10] Conclusion - Given the strong momentum indicators and positive earnings outlook, OHI is recommended as a solid pick for investors seeking near-term opportunities [12]

Group 1 - The article highlights the increasing importance of demographic dynamics, particularly focusing on companies involved in the aging population trend [1] - Skilled nursing facilities are identified as a significant area of interest within the broader context of the aging population [1]

Group 1 - The article highlights the increasing importance of demographic dynamics, particularly focusing on companies involved in the aging population trend [1] - Skilled nursing facilities are identified as a significant area of interest within the broader context of the aging population [1]

分组1 - Among healthcare REITs, Medical Properties Trust (MPW) and Omega Healthcare Investors (OHI) are highlighted for their similar and reasonably high yields and healthcare rental exposure [1] - The analysis emphasizes the potential investment opportunities in these two companies due to their strong positioning in the healthcare real estate sector [1] 分组2 - The article does not provide any specific financial metrics or performance data for MPW and OHI, focusing instead on their comparative yields and market positioning [1] - There is no mention of any risks or disclaimers related to the investment in these companies within the provided content [2][3]